Zhejiang Cancer Hospital: Carcinoma, Non-Small-Cell Lung trials

The registry lists 17 Carcinoma, Non-Small-Cell Lung studies with Zhejiang Cancer Hospital as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 11Phase 3 3No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• An Exploratory Clinical Study Of Bempemab Combined With Anlotinib As First-Line Treatment For Elderly Patients With Locally Advanced Or Metastatic Non-Small-Cell Lung CancerNot yet recruitingNCT07849712Not applicable
• Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain MetastasesNot yet recruitingNCT07343479Phase 2
• Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction ImmunochemotherapyNot yet recruitingNCT06031597Phase 3
• Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study.Active, not recruitingNCT06195683Phase 2
• SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint InhibitorsStatus unknownNCT05387044Phase 2
• Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung CancerCompletedNCT04266691
• Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)Status unknownNCT04255836Phase 2
• Acquired Resistant Mechanism of the First-generation EGFR TKIsStatus unknownNCT02804217
• Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLCStatus unknownNCT02481661Phase 3
• Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by ResectionStatus unknownNCT01926483Phase 2
• Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLCCompletedNCT01733589Phase 1/2
• Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung CancerStatus unknownNCT01688713Phase 2
• Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung CancerCompletedNCT01514877Phase 2
• Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)Status unknownNCT01158170Phase 3
• Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)Status unknownNCT01158144Phase 2
• Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)Status unknownNCT01091376Phase 2
• A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)Status unknownNCT00886678Phase 2